Extensive Genome-Wide Variability of Human Cytomegalovirus in Congenitally Infected Infants

Nicholas Renzette, Bornali Bhattacharjee, Jeffrey D. Jensen, +2

PLoS Pathogens

Rna Virus PopulationsViral EvolutionRna GenomesViral PersistenceMedicine +10

Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness

Ruian Ke, Pamela P. Martinez, Rebecca L. Smith, +36

Nature Microbiology

Viral EvolutionVirus EpidemiologyCovid-19 PandemicViral DynamicVirology +7

Longitudinal Assessment of Diagnostic Test Performance Over the Course of Acute SARS-CoV-2 Infection

Rebecca L. Smith, Laura Gibson, Pamela P. Martinez, +31

The Journal of Infectious Diseases

Limits and patterns of cytomegalovirus genomic diversity in humans

Nicholas Renzette, Cornelia Pokalyuk, Laura Gibson, +8

Proceedings of the National Academy of Sciences

AAV gene therapy for Tay-Sachs disease

Terence R. Flotte, Oğuz Çataltepe, Ajit S Puri, +27

Nature Medicine

Gene TherapiesAav Gene TherapyPathogenesisPathologyAntisense Therapy +3

Human Cytomegalovirus Proteins pp65 and Immediate Early Protein 1 Are Common Targets for CD8+ T Cell Responses in Children with Congenital or Postnatal Human Cytomegalovirus Infection

Laura Gibson, Giampiero Piccinini, Daniele Lilleri, +5

The Journal of Immunology

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno, +351

The Lancet Infectious Diseases

VaccinationVaccine SafetyTwo-dose Heterologous Ad26.zebovEmerging Infectious DiseasesVaccine Testing +7

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

David Ishola, Daniela Manno, Muhammed O. Afolabi, +107

The Lancet Infectious Diseases

VaccinationVaccine SafetyTwo-dose Heterologous Ad26.zebovVaccine DevelopmentEmerging Infectious Diseases +8

Infrequent Detection of HIV-1-Specific, But Not Cytomegalovirus-Specific, CD8+ T Cell Responses in Young HIV-1-Infected Infants

Zachary Scott, Ellen G. Chadwick, Laura Gibson, +8

The Journal of Immunology

The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak

Mohamed Samai, Jane F. Seward, Susan T. Goldstein, +28

The Journal of Infectious Diseases

VaccinationVaccine SafetyClinical Trial DesignVaccine Against EbolaClinical Endpoint +12